NEW

4 Groups Provide Guidance on Maintaining Essential Operations

ACS, AHA, ASA and AORN develop roadmap for safely managing surgical patients during a time of resurgence

Exactech Appoints New Chief Financial Officer

Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, has announced Kerem Bolukbasi as its new chief financial officer (CFO). Bolukbasi joins Exactech from TPG Capital where he...

Philips launches Rapid Equipment Deployment Kit to COVID-19 response

Royal Philips has introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses, technicians and hospital staff to quickly support critical care patient monitoring capabilities during the COVID-19 pandemic. Currently successfully in use in...

Pure Processing Hires New CFO

Pure Processing LLC, developer and provider of pre-cleaning stations, technologies and accessories for health care reprocessing departments, has announced the appointment of Carrie Pasinski, an experienced finance and operations leader, as chief financial officer for...

New Study Validates UV Disinfection Technology

A new study has been published regarding Tru-D and its deployment at Virginia Commonwealth University Health System (VCU). The study, “Deployment of a touchless ultraviolet light robot for terminal room disinfection: The importance of audit and feedback,” appeared online recently in the American Journal of Infection Control.

The study was conducted at VCU. Data was collected during a 25-month period from February 1, 2015-February 28, 2017. During the study, there were 420,394 patient days and 99,184 admissions. In the study, VCU set a goal of 90 percent utilization of the Tru-D robots for high-risk rooms. Through Tru-D’s real-time usage-tracking features and by educating environmental services (ES) on the importance of patient safety, VCU achieved 100 percent utilization.

The study stated, “The deployment was performed with structured education, audit and feedback, and resulted in a multidisciplinary practice change that maximized the UV disinfection capture rate from 20 percent to 100 percent.” From February 2015 until January 2017, two Tru-D robots were used, and in mid-January 2017, two additional robots were purchased.

“This study is a testament to the process of implementing a successful UV disinfection program and maximizing utilization,” said Alice Brewer, director of clinical affairs for tru-d smartuvc. “vcu was ultimately able to achieve 100 percent utilization on the highest risk rooms due to Tru-D’s data portal along with our strategic approach to Program Management.”

Validated by more than a dozen independent studies including the only randomized clinical trial on UV disinfection, Tru-D’s technology has been proven by science to provide a safer patient environment.

To learn more or to read independent studies, visit Tru-D.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X